Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AK Medical Holdings Ltd. ( (HK:1789) ) just unveiled an update.
AK Medical Holdings Limited has scheduled a board meeting for 25 March 2026 at its Global Operation Center in Beijing to review and approve the group’s annual results for the financial year ended 31 December 2025. The board will also consider recommending a final dividend and address other corporate matters, a step that could influence shareholder returns and provide updated visibility on the company’s financial performance and strategy.
The announcement confirms the current composition of the board, including executive, non-executive and independent non-executive directors, underscoring the governance framework under which these decisions will be made. Investors and other stakeholders will closely watch the forthcoming results and dividend decision for signals on the company’s operational momentum and capital allocation priorities.
The most recent analyst rating on (HK:1789) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on AK Medical Holdings Ltd. stock, see the HK:1789 Stock Forecast page.
More about AK Medical Holdings Ltd.
AK Medical Holdings Limited is a Cayman Islands–incorporated company listed in Hong Kong under stock code 1789. The group operates through subsidiaries and is overseen by a board that includes executive, non-executive and independent non-executive directors based in mainland China and Hong Kong, reflecting a structured corporate governance setup for its medical-related operations.
Average Trading Volume: 3,946,057
Technical Sentiment Signal: Hold
Current Market Cap: HK$6.6B
For a thorough assessment of 1789 stock, go to TipRanks’ Stock Analysis page.